Cargando…

Efficacy of Co-Trimoxazole against Experimental Melioidosis Acquired by Different Routes of Infection

Burkholderia pseudomallei is the causative agent of melioidosis and presents with diverse clinical manifestations. Naturally occurring infection occurs following contamination of cuts or skin abrasions, or ingestion of contaminated water, and occasionally through inhalational of infected soil or wat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nelson, Michelle, Burton, Neil, Nunez, Alejandro, Butcher, Wendy, Ngugi, Sarah, Atkins, Timothy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Clinical Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664850/ https://www.ncbi.nlm.nih.gov/pubmed/36226972 http://dx.doi.org/10.1128/aac.00708-22

Ejemplares similares

The lymphatic system as a potential mechanism of spread of melioidosis following ingestion of Burkholderia pseudomallei
por: Nelson, Michelle, et al.
Publicado: (2021)

Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using In Vitro and In Vivo Models of Q Fever
por: Clay, K. A., et al.
Publicado: (2021)

Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review
por: Keragala, Keragala Arachchige Reshani Kaumada, et al.
Publicado: (2023)

Comparison of Experimental Middle East Respiratory Syndrome Coronavirus Infection Acquired by Three Individual Routes of Infection in the Common Marmoset
por: Nelson, Michelle, et al.
Publicado: (2022)

Consensus on the Development of Vaccines against Naturally Acquired Melioidosis
por: Limmathurotsakul, Direk, et al.
Publicado: (2015)

Protection against Experimental Melioidosis following Immunisation with a Lipopolysaccharide-Protein Conjugate
por: Scott, Andrew E., et al.
Publicado: (2014)

Route of Infection in Melioidosis
por: Barnes, Jodie L., et al.
Publicado: (2005)

GC-072, a Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens
por: Shearer, Jeffry D., et al.
Publicado: (2019)

Melioidosis Acquired by Traveler to Nigeria
por: Salam, Alex P., et al.
Publicado: (2011)

Characterization of lesion formation in marmosets following inhalational challenge with different strains of Burkholderia pseudomallei
por: Nelson, Michelle, et al.
Publicado: (2016)

Efficient Treatment of Experimental Cerebral Malaria by an Artemisone-SMEDDS System: Impact of Application Route and Dosing Frequency
por: Zech, Johanna, et al.
Publicado: (2021)

Protection against Experimental Melioidosis with a Synthetic manno-Heptopyranose Hexasaccharide Glycoconjugate
por: Scott, Andrew E., et al.
Publicado: (2016)

Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei
por: Barnes, Kay B., et al.
Publicado: (2017)

Comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients
por: Khorvash, Farzin, et al.
Publicado: (2016)

Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis
por: Wijnant, Gert-Jan, et al.
Publicado: (2017)

Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors
por: Morgillo, F, et al.
Publicado: (2011)

Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial
por: McCurdy, Sandra, et al.
Publicado: (2020)

The Antibiotic Negamycin Crosses the Bacterial Cytoplasmic Membrane by Multiple Routes
por: Hörömpöli, Daniel, et al.
Publicado: (2021)

Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial
por: Sandison, Taylor G, et al.
Publicado: (2011)

Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits
por: Petraitis, Vidmantas, et al.
Publicado: (2022)

Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration
por: Mansilla, María José, et al.
Publicado: (2023)

Exposure–Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP
por: Gao, Wei, et al.
Publicado: (2022)

Association between activities related to routes of infection and clinical manifestations of melioidosis
por: Lim, C., et al.
Publicado: (2016)

Safety and Efficacy of Co-Trimoxazole for Treatment and Prevention of Plasmodium falciparum Malaria: A Systematic Review
por: Manyando, Christine, et al.
Publicado: (2013)

The Treatment of Melioidosis
por: Inglis, Timothy J.J.
Publicado: (2010)

Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients
por: Plantaz, Milan M. E. A., et al.
Publicado: (2020)

An In Vitro Evaluation of the Antibacterial Efficacy of Solanum xanthocarpum Extracts on Bacteria From Dental Plaque Biofilm
por: Arumuganainar, Deepavalli, et al.
Publicado: (2023)

Preparation and Evaluation of Rifampicin and Co-trimoxazole-loaded Nanocarrier against Brucella melitensis Infection
por: Bodaghabadi, Narges, et al.
Publicado: (2018)

Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes
por: Hughes, Derralynn A, et al.
Publicado: (2023)

miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer
por: Shen, Y, et al.
Publicado: (2013)

Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin
por: Colmegna, B, et al.
Publicado: (2015)

Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™
por: Losada, A, et al.
Publicado: (2004)

No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan
por: Calvet, L, et al.
Publicado: (2004)

Short‐Term Efficacy Reliably Predicts Long‐Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model‐Based Meta‐Analysis
por: Wang, Yehong, et al.
Publicado: (2015)

Low risk of acquiring melioidosis from the environment in the continental United States
por: Hall, Carina M., et al.
Publicado: (2022)

Resistance gene pool to co-trimoxazole in non-susceptible Nocardia strains
por: Valdezate, Sylvia, et al.
Publicado: (2015)

Acute glycaemic effects of co-trimoxazole at prophylactic dose in healthy adults
por: Kenteu, Bernold, et al.
Publicado: (2016)

Incidence of Co-Trimoxazole-Induced Hyperkalemia in a Tertiary Care Hospital
por: Al AdAwi, Rana M, et al.
Publicado: (2021)

Efficacy of Delafloxacin against the Biothreat Pathogen Burkholderia pseudomallei
por: McCurdy, Sandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bmcs07jb0i5k4khgr1eu0lqq5h